Devyser Diagnostics AB Cash Flow Reinvestment Rate
Devyser Diagnostics AB cash flow reinvestment rate. Devyser Diagnostics AB (DVYSR) has a Cash Flow Reinvestment Rate of 1.17x as of June 2026, reinvesting Skr14.40 Million (capex Skr14.40 Million ) from operating cash flow of Skr12.30 Million. Explore Devyser Diagnostics AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Devyser Diagnostics AB (2018–2025)
Cash flow reinvestment rate of Devyser Diagnostics AB from 2018 to 2025. Historical reinvestment intensity for Devyser Diagnostics AB across 4 annual periods. Explore reinvestment intensity of Devyser Diagnostics AB to see what proportion of operating cash flow is directed to capital expenditures.
Devyser Diagnostics AB Cash Flow Reinvestment Rate by Year (2018–2025)
Devyser Diagnostics AB cash flow reinvestment rate by year from 2018 to 2025. Year-by-year capital reinvestment analysis for Devyser Diagnostics AB. For the full cash flow conversion analysis, see Devyser Diagnostics AB operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | Skr2.00 Million | Skr8.20 Million | Skr1.50 Million | ▼ -98.1% |
| 2020 | 12.96x | Skr8.13 Million | Skr627.00K | Skr3.41 Million | ▲ +1936.5% |
| 2019 | 0.64x | Skr9.31 Million | Skr14.63 Million | Skr9.31 Million | ▼ -24.3% |
| 2018 | 0.84x | Skr5.06 Million | Skr6.02 Million | Skr5.06 Million | — |